Comprehensive Analysis of CRIP1 in Patients with Ovarian Cancer, including ceRNA Network, Immune-Infiltration Pattern, and Clinical Benefit

Table 1

Clinical characteristics of OC patients in the TCGA database.

Characteristic	Overall
	379
Age, (%)
≤60	208 (54.9%)
>60	171 (45.1%)
FIGO stage, (%)
Stage I	1 (0.3%)
Stage II	23 (6.1%)
Stage III	295 (78.5%)
Stage IV	57 (15.2%)
Histologic grade, (%)
G1	1 (0.3%)
G2	45 (12.2%)
G3	322 (87.3%)
G4	1 (0.3%)
Anatomic neoplasm, (%)
Unilateral	102 (28.6%)
Bilateral	255 (71.4%)
Venous invasion, (%)
No	41 (39%)
Yes	64 (61%)
Lymphatic invasion, (%)
No	48 (32.2%)
Yes	101 (67.8%)
Tumor residual, (%)
NRD	67 (20%)
RD	268 (80%)
Tumor status, (%)
Tumor free	72 (21.4%)
With tumor	265 (78.6%)